Design of benzophenone-containing photoactivatable linear vasopressin antagonists: Pharmacological and photoreactive properties

Journal of Medicinal Chemistry

Volumn 48, Issue 9, 2005, Pages 3379-3388

  Ponthieux, Sylvie ^a   Cabot, Joëlle ^a   Mouillac, Bernard ^a   Seyer, René ^a   Barberis, Claude ^a   Carnazzi, Eric ^a  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPHENONE; IODINE 125; PHENYLACETYL DEXTRO BENZOYLPHENYLALANYLPHENYLALANYLGLUTAMINYLASPARAGINYLARGINYLPROLYLARGINYLTYROSINA MIDE; PHENYLACETYLBENZOYLPHENYLALANYLPHENYLALANYLGLUTAMINYLASPARAGINYLARGINYLPROL YLARGINYLTYROSINAMIDE; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V1A RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; DISSOCIATION CONSTANT; DRUG DESIGN; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION;

ANIMALS; BENZOPHENONES; BINDING SITES; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; IODINE RADIOISOTOPES; KINETICS; LIGHT; OLIGOPEPTIDES; PHOTOAFFINITY LABELS; RADIOLIGAND ASSAY; RECEPTORS, VASOPRESSIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 18244380327     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040871+     Document Type: Article

References (41)

1. Jard, S.; Elands, J.; Schmidt, A.; Barberis, C. Vasopressin and oxytocin receptors: an overview. Progress in Endocrinology; Elsevier: Amsterdam, 1988; pp 1183-1189.
2. Morel, A.; O'Carroll, A. M.; Brownstein, M. J.; Lolait, S. J. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 1992, 356, 523-526.
3. Hirasawa, A.; Shibata, K.; Kotosai, K.; Tsujimoto, G. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem. Biophys, Res. Commun. 1994, 203, 72-79.
4. Hutchins, A. M.; Phillips, P. A.; Venter, D. J.; Burrell, L. M.; Johnston, C. I. Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor. Biochim. Biophys. Acta 1995, 1263, 266-270.
5. Thibonnier, M.; Auzan, C.; Madhun, Z.; Wilkins, P.; Berti-Mattera, L.; Clauser, E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. Biol. Chem. 1994, 269, 3304-3310.
6. Mouillac, B.; Chini, B.; Balestre, M. N.; Elands, J.; Trumpp-Kallmeyer, S.; Hoflack, J.; Hibert, M.; Jard, S.; Barberis, C. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J. Biol. Chem. 1995, 270, 25771-25777.
7. Phalipou, S.; Cotte, N.; Carnazzi, E.; Seyer, E.; Mahe, E.; Jard, S.; Barberis, C.; Mouillac, B. Mapping peptide-binding domains of the human Via vasopressin receptor with a photoactivatable linear peptide antagonist. J. Biol. Chem. 1997, 272, 26536-26544.
8. Phalipou, S.; Seyer, R.; Cotte, N.; Breton, C.; Barberis, C.; Hibert, M.; Mouillac, B. Docking of linear peptide antagonists into the human V1a vasopressin receptor. Identification of binding domains by photoaffinity labeling. J. Biol. Chem. 1999, 274, 23316-23327.
9. Carnazzi, E.; Aumelas, A.; Barberis, C.; Guillon, G.; Seyer, R. A new series of photoactivatable and iodinatable linear vasopressin antagonists. J. Med. Chem. 1994, 37, 1841-1849.
10. Carnazzi, E.; Aumelas, A.; Phalipou, S.; Mouillac, B.; Guillon, G.; Barberis, C.; Seyer, R. Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist. Eur. J. Biochem. 1997, 247, 906-913.
11. Manning, M.; Stoev, S.; Kolodziejczyk, A.; Klis, W. A.; Kruszynski, M.; Misicka, A.; Olma, A.; Wo, N. C.; Sawyer, W. H. Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin. J. Med. Chem. 1990, 33, 3079-3086.
12. Dorman, G.; Prestwich, G. D. Using photolabile ligands in drug discovery and development. Trends Biotechnol. 2000, 18, 64-77.
13. Weber, P. J.; Beck-Sickinger, A. G. Comparison of the photochemical behavior of four different photoactivatable probes. J. Pept. Res. 1997, 49, 375-383.
14. Dorman, G.; Prestwich, G. D. Benzophenone photophores in biochemistry. Biochemistry 1994, 33, 5661-5673.
15. Kage, R.; Leeman, S. E.; Krause, J. E.; Costello, C. E.; Boyd, N. D. Identification of methionine as the site of covalent attachment of a p-benzoyl-phenylalanine-containing analogue of substance P on the substance P (NK-1) receptor. J. Biol. Chem. 1996, 271, 25797-25800.
16. Sachon, E.; Bolbach, G.; Chassaing, G.; Lavielle, S.; Sagan, S. Cgamma H2 of Met174 side chain is the site of covalent attachment of a substance P analogue photoactivable in position 5. J. Biol. Chem. 2002, 277, 50409-50414.
17. Behar, V.; Bisello, A.; Rosenblatt, M.; Chorev, M. Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking. Endocrinology 1999, 140, 4251-4261.
18. Kauer, J. C.; Erickson-Viitanen, S.; Wolfe, H. R.; DeGrado, W. F. p-Benzoyl-L-phenylalanine, a new photoreactive amino acid. J. Biol. Chem. 1986, 261, 10695-10700.
19. Wilson, C. J.; Husain, S. S.; Stimson, E. R.; Dangott, L. J.; Miller, K. W.; Maggio, J. E. p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analogue amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor. Biochemistry 1997, 36, 4542-4551.
20. Dorman, G.; Olszewski, J. D.; Prestwich, G. D. Synthesis of highly tritiated 4-benzoyl-L-phenylalanine, a photoactivatable amino acid. J. Org. Chem. 1995, 60, 2292-2297.
21. Carnazzi, E.; Aumelas, A.; Mouillac, B.; Breton, C.; Guillou, L.; Barberis, C.; Seyer, R. Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist. J. Med. Chem. 2001, 44, 3022-3030.
22. Barberis, C.; Balestre, M. N.; Jard, S.; Tribollet, E.; Arsenijenic, Y.; Dreifuss, J. J.; Bankowski, K.; Manning, M.; Chan, W. Y.; Schlosser, S. S.; Holsboer, F.; Elands, J. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors. Neuroendocrinology 1995, 62, 135-146.
23. Manning, M.; Lammek, B.; Kolodziejczyk, A. M.; Seto, J.; Sawyer, W. H. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin. J. Med. Chem. 1981, 24, 701-706.
24. Jones, D. A., Jr.; Sawyer, W. H. N-Acetyl-[2-(O-methyl)tyrosine]- arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin. J. Med. Chem. 1980, 23, 696-698.
25. Marfey, P. Determination of D-amino acids. II. Use of a bifunctional reagent, 1,5-difluoro-2,4-dinitrobenzene. Carlsberg Res. Commun. 1984, 49, 591-596.
26. Breton, C.; Chellil, H.; Kabbaj-Benmansour, M.; Carnazzi, E.; Seyer, R.; Phalipou, S.; Morin, D.; Durroux, T.; Zingg, H.; Barberis, C.; Mouillac, B. Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor. J. Biol. Chem. 2001, 276, 26931-26941.
27. Servant, G.; Laporte, S. A.; Leduc, R.; Escher, E.; Guillemette, G. Identification of angiotensin II-binding domains in the rat AT2 receptor with photolabile angiotensin analogs. J. Biol. Chem. 1997, 272, 8653-8659.
28. Li, Y. M.; Marnerakis, M.; Stimson, E. R.; Maggio, J. E. Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists. J. Biol. Chem. 1995, 270, 1213-1220.
29. Thiele, C.; Fahrenholz, F. Photoaffinity labeling of central cholecystokinin receptors with high efficiency. Biochemistry 1993, 32, 2741-2746.
30. Guillemette, G.; Guillon, G.; Marie, J.; Balestre, M. N.; Escher, E.; Jard, S. High yield photoaffinity labeling of angiotensin II receptors. Mol. Pharmacol. 1986, 30, 544-551.
31. Bosse, R.; Servant, G.; Zhou, L. M.; Boulay, G.; Guillemette, G.; Escher, E. Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor. Regul. Pept. 1993, 44, 215-223.
32. Manning, M.; Olma, A.; Klis, W. A.; Kolodziejczyk, A. M.; Seto, J.; Sawyer, W. H. Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin. J. Med. Chem. 1982, 25, 45-50.
33. Hruby, V. J.; Upson, D. A.; Yamamoto, D. M.; Smith, C. W.; Walter, R. Active site studies of neurohypophyseal hormones. Comparison of oxytocin and arginine vasopressin analogues containing 2-D-tyrosine. J. Am. Chem. Soc. 1979, 101, 2717.
34. Manning, M.; Sawyer, W. H. Antagonists of vasopressor and antidiuretic responses to arginine vasopressin. Ann. Intern. Med. 1982, 96, 520-522.
35. Manning, M.; Lammek, B.; Bankowski, K.; Seto, J.; Sawyer, W. H. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin. J. Med. Chem. 1985, 28, 1485-1491.
36. Saunders, J. A.; Saunders, J. M.; Morris, S.; Spencer, A. W. Amino acid analysis of subcellular fractions by PITC and OPA. Chromatogram 1988, 9, 2-5.
37. Park, C.; Chamberlin, M. E.; Pan, C. J.; Chou, J. Y. Differential expression and butyrate response of human alkaline phosphatase genes are mediated by upstream DNA elements. Biochemistry 1996, 35, 9807-9814.
38. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
39. Munson, P. J.; Rodbard, D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980, 107, 220-239.
40. Audigier, S.; Barberis, C. Pharmacological characterization of two specific binding sites for neurohypophyseal hormones in hippocampal synaptic plasma membranes of the rat. EMBO J. 1985, 4, 1407-1412.
41. Chini, B.; Mouillac, B.; Balestre, M. N.; Trumpp-Kallmeyer, S.; Hoflack, J.; Hibert, M.; Andriolo, M.; Pupier, S.; Jard, S.; Barberis, C. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett. 1996, 397, 201-206.